Giant Biogene Holding Co., Ltd.
2367
Rankning i aktier
#5026
Giant Biogene Holding Co., Ltd. operates as an investment holding entity,... Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic of China. The company also manufactures functional foods leveraging rare ginsenosides technology and provides medical devices. Its diverse product range, which includes specialized skincare, medical dressings, and nutritional supplements, is marketed predominantly under brand names such as Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan. Established in 2000, Giant Biogene Holding Co., Ltd. maintains its headquarters in Xi'an, PRC.
Aktiekurs
$2.67
Marknadsvärde
$2.84B
Förändring (1 dag)
-6.09%
Förändring (1 år)
-46.20%
Land
CN
Handel Giant Biogene Holding Co., Ltd. (2367)
Kategori
Consumer Defensive
Utdelningsavkastning för Giant Biogene Holding Co., Ltd. (2367)
Utdelningsavkastningen (TTM) för Giant Biogene Holding Co., Ltd. (aktiesymbol: 2367) per 2024-12-31 är: 1.94%
Genomsnittlig utdelningsavkastning de senaste 5 åren: 3.84%
Genomsnittlig utdelningsavkastning de senaste 5 åren: 3.84%
Historik för utdelningsavkastning för Giant Biogene Holding Co., Ltd. (2367) från 2019 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
| År | Utdelningsavkastning | Ändra |
|---|---|---|
| 2026 (TTM) | 6.62% | 68.02% |
| 2025 | 3.94% | 103.09% |
| 2024 | 1.94% | 0.00% |
| 2023 | 0.00% | -100.00% |
| 2022 | 1.27% | -89.44% |
| 2021 | 12.03% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter
| Företag | Utdelningsavkastning | Land |
|---|---|---|
| 2.76% |
US
|
|
| 1.88% |
FR
|
|
| 2.26% |
US
|
|
| 2.24% |
IN
|
|
| 1.35% |
US
|
